Sigma-Aldrich

Germany’s Merck may See EC Fine over Sigma-Aldrich

Merck KGaA Expands Roche Reagents Pact

Opportunities in Drug Development and Manufacturing

Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active pharmaceutical ingredients (APIs) and finished drug products.

KPMG Expects 2016 to become Another Record Year for M&A in the Pharmaceutical Industry

Sigma-Aldrich now Part of Merck KGaA

Nov. 18 Closing for Sigma-Aldrich Takeover by Merck KGaA

Sigma-Aldrich-Honeywell Deal Advances Merck Takeover

Johnson Matthey Acquires Pharmorphix

Merck to Close on Sigma-Aldrich in Q4

Significant Value Creation

Germany’s Merck Wins Last Antitrust Nod for Sigma-Aldrich

Merck KGaA to Buy all of Quantum Materials Firm

EU Approves Merck KGaA’s Takeover of Sigma-Aldrich

Merck Appoints Udit Batra to Head Combined Life Science Business

Merck KGaA Places €1.5 Billion Bond for Sigma-Aldrich Deal

Sigma-Aldrich Shareholders Approve Takeover by Merck

Sigma-Aldrich to Acquire Reagents Maker Cell Marque

Moody Reviews German Merck’s Credit Rating

Merck KGaA to Buy Sigma-Aldrich for $17 billion

U.S. API Manufacturing and Sustainability

Highly Potent API Demand is On the Rise

SAFC Wins Commercial Licensing of CHOZN Platform in Asia

Thermo Fisher takes over Life Technologies for $13.6 Billion

SAFC, CrystalGenomics Sign Collaboration Agreement

Sigma-Aldrich Acquires Research Organics

Peter Pollak on the World of Fine Chemicals

Sigma-Aldrich Q2 Profit Rises

Fine Chemicals: The Top 10

Sigma-Aldrich CEO Jai Nagarkatti Dies